Catalysts for Teva Pharmaceuticals USA Inc
453 tracked
Apr 17, 2020
approval
VIGABATRIN — FDA approval
Teva Pharmaceuticals USA Inc
→
Nov 25, 2019
approval
NIZORAL ANTI-DANDRUFF (KETOCONAZOLE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Oct 7, 2019
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Oct 7, 2019
approval
FENTORA (FENTANYL CITRATE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Oct 7, 2019
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Oct 7, 2019
approval
ACTIQ (FENTANYL CITRATE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Sep 12, 2019
approval
VIGABATRIN — FDA approval
Teva Pharmaceuticals USA Inc
→
Sep 12, 2019
approval
VIGABATRIN — FDA approval
Teva Pharmaceuticals USA Inc
→
May 30, 2019
approval
VIGABATRIN — FDA approval
Teva Pharmaceuticals USA Inc
→
May 30, 2019
approval
VIGABATRIN — FDA approval
Teva Pharmaceuticals USA Inc
→
Jan 16, 2019
approval
CLOZAPINE — FDA approval
Teva Pharmaceuticals USA Inc
→
Jan 16, 2019
approval
CLOZAPINE — FDA approval
Teva Pharmaceuticals USA Inc
→
Jan 14, 2019
approval
VIGABATRIN — FDA approval
Teva Pharmaceuticals USA Inc
→
Nov 30, 2018
approval
NIZORAL ANTI-DANDRUFF (KETOCONAZOLE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Oct 31, 2018
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Oct 16, 2018
approval
OXALIPLATIN — FDA approval
Teva Pharmaceuticals USA Inc
→
Sep 18, 2018
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Sep 18, 2018
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Sep 18, 2018
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Sep 18, 2018
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Sep 18, 2018
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Aug 31, 2018
approval
CLARAVIS (ISOTRETINOIN) — FDA approval
Teva Pharmaceuticals USA Inc
→
Aug 31, 2018
approval
CLARAVIS (ISOTRETINOIN) — FDA approval
Teva Pharmaceuticals USA Inc
→
Jul 19, 2018
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
May 2, 2018
approval
CLARAVIS (ISOTRETINOIN) — FDA approval
Teva Pharmaceuticals USA Inc
→
May 2, 2018
approval
CLARAVIS (ISOTRETINOIN) — FDA approval
Teva Pharmaceuticals USA Inc
→
Apr 23, 2018
approval
CLARAVIS (ISOTRETINOIN) — FDA approval
Teva Pharmaceuticals USA Inc
→
Apr 23, 2018
approval
CLARAVIS (ISOTRETINOIN) — FDA approval
Teva Pharmaceuticals USA Inc
→
Apr 23, 2018
approval
VIGABATRIN — FDA approval
Teva Pharmaceuticals USA Inc
→
Feb 1, 2018
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
Teva Pharmaceuticals USA Inc
→